share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Nov 5 05:45

Summary by Moomoo AI

Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more